SCHEMBL4653101

SCHEMBL4653101

N=C(N)NCCC[C@@H](NC(=O)C(c1ccccc1)C1CCCC1)C(=O)NCc1ccc(O)cc1

nearest known ligand 0.54

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
▸ NPY1R P25929 18/20 0.54
▸ NPY5R Q15761 3/20 0.53
▸ NPFFR1 Q9GZQ6 2/20 0.53
▸ NPFFR2 Q9Y5X5 2/20 0.53
▸ NPY4R P50391 4/20 0.47
▸ NPY2R P49146 2/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4653106 0.87 TP53 (0.44) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL650331 0.85 NPY1R (0.72) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL31652661 0.85 NPY1R (0.50) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL31652535 0.84 NPY1R (0.54) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL31652720 0.83 NPY1R (0.52) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL31652820 0.83 NPY1R (0.54) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL13449162 0.83 TP53 (0.46) —
SCHEMBL9202898 0.82 NPY1R (0.40) NPY1RNPY5RNPFFR1NPFFR2NPY4R
SCHEMBL13450342 0.82 NPY4R (0.45) NPY1RNPY5RNPY4RNPY2R
SCHEMBL31652623 0.82 NPY1R (0.53) NPY1RNPY5RNPFFR1NPFFR2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 7 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0680469-B1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME BOEHRINGER INGELHEIM PHARMA (DE) 2000-04-26 — — EP claimed
EP-1093803-B1 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor SANOFI AVENTIS (FR) 2008-09-17 — — EP disclosed
EP-0838217-B1 Cosmetic composition containing neuropeptide Y receptor antagonist SANOFI SYNTHELABO (FR) 2003-01-15 — — EP disclosed
US-6313128-B1 CAN BE USED AS LYPOLYSIS/LYPOGENESIS REGULATORS IN THE SKIN WITHOUT, INTERFERRING WITH THE SKIN'S NATURAL FUNCTIONS; FOR THERAPY OF SABORRHEA AND ACNE SANOFI-SYNTHELABO (FR) 2001-11-06 — — US disclosed
EP-1132463-A2 Cosmetic composition comprising an antagonist of the neuropeptide Y receptor SANOFI-SYNTHELABO (FR) 2001-09-12 — — EP disclosed
EP-0680469-B1 AMINOACID DERIVATES, MEDICAMENTS CONTAINING THESE COMPOUNDS AND PROCESS FOR PREPARING THE SAME BOEHRINGER INGELHEIM PHARMA (DE) 2000-04-26 — — EP disclosed
EP-0838217-A2 Cosmetic composition containing neuropeptide Y receptor antagonist SANOFI (FR) 1998-04-29 — — EP disclosed
Send feedback